Reflections on the Early History of National Institute on Drug Abuse (NIDA): Implications for Today
Published date | 01 January 2009 |
Date | 01 January 2009 |
DOI | 10.1177/002204260903900101 |
Author | Robert L. DuPont |
Subject Matter | Article |
© 2009 BY THE JOURNAL OF DRUG ISSUES
JOURNAL OF DRUG ISSUES 0022-0426/09/01 5-14
__________
Robert L. DuPont, MD, the fi rst Director of the National Institute on Drug Abuse, is President of the
Institute for Behavior and Health, Inc., a nonprofi t organization that promotes ideas to reduce illegal
drug use. He is a practicing psychiatrist and Clinical Professor of Psychiatry at Georgetown Medical
School. Over his career, he has advocated change in federal drug policy to emphasize treatment and
research.
REFLECTIONS ON THE EARLY HISTORY OF NATIONAL
INSTITUTE ON DRUG ABUSE (NIDA): IMPLICATIONS
FOR TODAY
ROBERT L. DUPONT
The National Institute on Drug Abuse (NIDA) was formed in September, 1973 from
a Division of the National Institute on Mental Health (NIMH), from the three-decade
old Addiction Research Center (ARC) in Lexington Kentucky, and from the two year
old Special Action Offi ce for Drug Abuse Prevention (SAODAP), the original White
House drug offi ce. The legislation authorizing NIDA was passed by both Houses
of Congress and signed by the president with bipartisan unanimity in response
to the drug abuse epidemic, which had begun in the late 1960s. NIDA was the
embodiment of the new Federal drug abuse strategy that, for the fi rst time, balanced
the traditional focus on law enforcement (supply reduction) with a new focus on
treatment, prevention, and research (what became known as demand reduction).
The current article offers a review of the early history of NIDA and its implications
for future research.
INTRODUCTION
The National Institute on Drug Abuse (NIDA) sprang from the forced and unlikely
bureaucratic marriage of the White House Special Action Offi ce for Drug Abuse
Prevention (SAODAP) and the Division of Narcotic Abuse and Drug Addiction
(DNADA) within the National Institute of Mental Health (NIMH) in September,
1973.
The White House Special Action Offi ce for Drug Abuse Prevention was created
by executive order on June 17, 1971. Subsequent enabling legislation, signed into
law by the president on March 21, 1972, contained a sunset provision terminating
the offi ce on June 30, 1975. That same law authorized the creation of NIDA no
To continue reading
Request your trial